Position in FATE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$43,200
New position
Shares Held
16,000
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 152 holders
Holding Since
Jun 2026
1 quarter on record
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ameritas Advisory Services, LLC holds $690,036 across 47 Biotechnology names. FATE ranks #7 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
337 | $167,398 | |
| 2 | MRNA |
Moderna, Inc.
|
1,110 | $77,733 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119 | $74,201 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
1,018 | $55,521 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
256 | $47,943 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
193 | $46,507 | |
| 7 | FATE |
Fate Therapeutics Inc
This page
|
16,000 | $43,200 | |
| 8 | VCEL |
Vericel Corp
|
818 | $36,392 |
All Filings in FATE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,200 | 16,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||